In a 47-year-old, 99-kg patient with type 2 diabetes on insulin glargine (Lantus) 18 U, insulin‑sensitivity factor 25 mg/dL per unit, and insulin‑to‑carbohydrate ratio 1 U per 10 g, who ate 66 g carbohydrate at 5 pm and has blood glucose readings of 231 mg/dL at 8 pm, 240 mg/dL at 9 pm, and 201 mg/dL at 1 am and will be NPO after midnight, what should the basal insulin dose, insulin‑sensitivity factor, and insulin‑to‑carbohydrate ratio be adjusted to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Insulin Dose Adjustment Recommendation

Increase the Lantus dose to 20 units (approximately 10% increase from current 18 units), maintain the ISF at 25 mg/dL per unit, and keep the ICR at 1:10 g carbohydrate. 1

Rationale for Basal Insulin Adjustment

The blood glucose pattern reveals inadequate basal insulin coverage:

  • Pre-dinner BG: 231 mg/dL (elevated)
  • 8 PM BG: 240 mg/dL (minimal rise despite 66g CHO meal, suggesting meal insulin was appropriate)
  • 9 PM BG: 201 mg/dL (declining)
  • 1 AM BG: 201 mg/dL (stable overnight)

The fasting/pre-meal hyperglycemia (231 mg/dL) indicates insufficient basal insulin. The FDA label for Lantus recommends titration using evidence-based algorithms, such as increasing by 2 units every 3 days to reach fasting glucose goals without hypoglycemia 1. The 2025 ADA guidelines support systematic titration of basal insulin with increases of 1-2 units or 10-15% adjustments 2.

For this patient: A 2-unit increase (from 18 to 20 units) represents an 11% increase, which is appropriate given the fasting glucose of 231 mg/dL is well above target (<100-130 mg/dL for most patients).

NPO Considerations

Since the patient will be NPO after midnight:

  • Continue the Lantus at the adjusted dose of 20 units at the usual time (Lantus can be given at any consistent time of day) 1
  • Hold all mealtime/bolus insulin while NPO
  • Monitor blood glucose every 4-6 hours during the NPO period
  • Have correction insulin available using the ISF of 25 mg/dL per unit for hyperglycemia >180 mg/dL

The basal insulin provides background glucose control independent of meals and should be continued during NPO periods to prevent hyperglycemia 1. The relatively flat glucose curve from 9 PM to 1 AM (201 mg/dL) suggests the current basal dose provides stable overnight coverage without hypoglycemia risk.

ISF and ICR Assessment

No adjustment needed for ISF (25 mg/dL per unit) or ICR (1:10g):

The post-meal glucose pattern shows appropriate prandial insulin dosing:

  • 66g CHO ÷ 10 = 6.6 units meal insulin
  • Correction dose for BG 231: (231-120)/25 = 4.4 units
  • Total bolus: ~11 units
  • BG dropped from 231 → 201 mg/dL over 6 hours, indicating appropriate insulin sensitivity

The ISF and ICR appear well-calibrated based on the observed glucose response. The primary issue is inadequate basal coverage, not insulin sensitivity or carbohydrate ratio.

Monitoring During NPO Period

While NPO, check blood glucose:

  • Every 4-6 hours minimum
  • More frequently if <100 mg/dL or >250 mg/dL
  • Use correction insulin (rapid-acting) for BG >180 mg/dL: (BG - 120)/25 = units to give
  • Hold correction if BG <150 mg/dL to avoid stacking

Common Pitfalls to Avoid

  • Do not reduce basal insulin during NPO periods unless there is documented hypoglycemia—basal insulin is needed regardless of oral intake 1
  • Do not over-correct the basal dose too aggressively; 10-15% increases are appropriate 2
  • Do not give mealtime insulin while NPO, even if glucose is elevated—use correction doses instead
  • Do not mix or dilute Lantus with any other insulin or solution 1

References

Related Questions

For a 72‑year‑old woman with type 2 diabetes, weight 48.7 kg, normal renal function, currently taking insulin glargine (Lantus) 22 units daily, insulin sensitivity factor 50 mg/dL per unit, and carbohydrate‑to‑insulin ratio 7 g per unit, with blood glucose readings of 110 mg/dL at 18:00, 77 mg/dL at 21:00, and 73 mg/dL at 02:00 and 06:00, what should the basal insulin dose, insulin sensitivity factor, and carbohydrate‑to‑insulin ratio be adjusted to?
What initial dose of Lantus (insulin glargine) should be prescribed for a 60-year-old male with type 2 diabetes and an A1c of 9.9% who is medication‑naïve?
For a 45-year-old Hispanic male weighing 98.4 kg with newly diagnosed type 2 diabetes and normal renal function, currently on 30 U insulin glargine (Lantus) and an insulin-to-carbohydrate ratio of 1 U per 5 g carbohydrate, with post‑meal insulin drip rates of 6, 4, 8, 6 U and overnight fasting drip rates of 2 U each hour, what should the insulin-to-carbohydrate ratio, basal insulin glargine dose, and insulin sensitivity factor be?
In a 53‑year‑old, 37‑kg woman with type 2 diabetes, insulin resistance, and a high‑carbohydrate diet, currently using insulin glargine (Lantus) 24 units daily, an insulin‑to‑carbohydrate ratio of 6 g per unit, and an insulin‑sensitivity factor of 25 mg/dL per unit, what should her insulin‑sensitivity factor, insulin‑to‑carbohydrate ratio, and basal insulin dose be adjusted to?
After administering 10 units of morning basal insulin, the fasting glucose is 70 mg/dL; what adjustment, if any, should be made to the insulin dose?
Does a cerebellar lesion cause ipsilateral deviation of gaze and head?
Is the regimen of tadalafil 5 mg taken every 12 hours on alternate days prescribed at the clinic effective for erectile dysfunction?
What clinical and radiologic features reliably differentiate postpartum pre‑eclampsia from posterior reversible encephalopathy syndrome (PRES)?
In an 83-year-old with vitamin B12 deficiency anemia, macrocytosis (MCV 112 fL), positive intrinsic factor antibodies, and atrophic gastritis of the fundus and body, what follow‑up is recommended?
How can I determine on physical examination if a patient has a rib fracture?
Can taking Magmit (magnesium supplement) together with Gufis (antacid) cause abdominal pain?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.